BioCentury
ARTICLE | Company News

GlobeImmune cancer news

September 21, 2015 7:00 AM UTC

In August, GlobeImmune hired Cantor Fitzgerald & Co. to evaluate strategic options, including a merger or sale of all or part of the company. Earlier this year, Celgene Corp. (NASDAQ:CELG, Summit, N....